UNJHA Formulations Q1 FY27 Results: PAT drops to 15.69 lakh from 38.99 lakh YoY

Revenue declinedResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.5%Reaction day

₹27.25

prior close

₹28.75

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+4.2% vs market

Pharmaceuticals peers, median of 163sector+0.9%+4.6% vs sector

On the reaction day the stock moved 4.2 pts more than Nifty Microcap 250 and 4.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.5+1.3+4.2+0.9+4.6

Next day

-3.9+1.8-5.6+0.8-4.7

-7.9+3.1-11.0+0.3-8.2

-11.9+3.5-15.4+0.7-12.7

-12.3+3.5-15.7+1.5-13.7

-0.4+3.4-3.8+1.3-1.7

-0.9+3.6-4.6+1.6-2.6

15d

-8.3+4.9-13.1+0.9-9.1

+7.1+4.4+2.7+1.6+5.5

+17.4+2.9+14.5+1.5+16.0

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

UNJHA Formulations reported Q1 FY27 results. Net sales declined to 330.75 lakh from 361.41 lakh YoY, while total expenses came in at 314.98 lakh. Profit before tax fell to 15.69 lakh from 38.99 lakh in Q1 FY26, a drop of around 60 percent. PAT stood at 15.69 lakh versus 38.99 lakh, with EPS at 0.35 versus 0.87. The auditor issued an unqualified limited review report.

Likely market impact

Weak Q1 with sharp profit decline of about 60 percent YoY despite modest sales dip. Turnaround from Q4 FY26 loss but performance lags year ago.